3Spine
PrivateLast Round
Series C
Extension
Feb 21, 2025
Total Funding Raised
$74.53M
Company Overview
3Spine is a medical device company that develops total joint replacement technology for the lumbar spine as an alternative to spinal fusion.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
3Spine Comparables
Compare 3Spine with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Premia Spine | 89% | |
| AxioMed | 84% | |
| Centinel Spine | 84% | |
3Spine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Feb 21, 2025 | ||||
| Debt | Apr 26, 2024 | ||||
| Series C | Mar 15, 2022 | ||||
| Series B | Jun 23, 2021 | ||||
| Series A | Aug 10, 2020 | ||||
Series A | Jan 1, 2017 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2017
$7.3M round completed.
3Spine Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about 3Spine's valuation, stock price, and market status.